Effect Of Selinexor (Kpt-330), A Novel Oral Selective Inhibitor Of Nuclear Export (Sine), On Tumor Suppressors And Cell Cycle Proteins In Prostate Cancer Cells And Regression Of Castration-Resistant Patient-Derived Xenograft Tumor Growth.